Latest Financial Performance News

Urbanise.com Limited reported a 4.2% revenue increase for FY2025, driven by a landmark partnership and equity investment from National Australia Bank. The company achieved positive operating cash flow for the fourth consecutive quarter, setting the stage for its next growth phase.

Aroa Biosurgery has reported its third consecutive quarter of positive net cash flow, maintaining a strong cash position and reaffirming its FY26 revenue and EBITDA guidance. The company’s Myriad product sales continue to grow, supported by new clinical evidence.

Freelancer Limited has reported its strongest half-year profit to date, driven by growth across its freelancing, escrow, and freight platforms, while setting ambitious targets for AI productisation and double-digit revenue growth in FY25.

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

BSA Limited reported a 7% increase in FY25 revenue to $286.8 million and a 42% rise in EBITDA pre-significant items, despite losing key contracts that accounted for 92% of its revenue. The company is undertaking significant restructuring to navigate these challenges.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Turners Automotive Group has issued over 324,000 new shares under its Dividend Reinvestment Plan for the FY25 final dividend, slightly increasing its capital base.

Freelancer Limited has posted a notable financial turnaround in the first half of 2025, reporting a net profit of $1.9 million on the back of 8.5% revenue growth and improved cash flow. The company’s strengthened balance sheet and strategic share acquisition position it well for future growth.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Resolute Mining delivered steady gold production in Q2 2025 while progressing its strategic expansion with the Doropo acquisition and promising Bantaco resource estimates. The company remains on track for its 2025 guidance despite operational challenges.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Sandfire Resources reported a 12% rise in copper equivalent production for FY25, narrowly missing guidance due to severe weather and power outages, while slashing net debt by $273 million. The company projects further growth in FY26 despite expected cost pressures.